News and Opinions

Durham, NC - A phase 2 clinical trial whose results were released today in STEM CELLS Translational Medicine might point to a way to overcome bronchopulmonary dysplasia (BPD), a major cause of death in preterm infants. The study, conducted by researchers at Samsung...

Durham, NC – A study released today in STEM CELLS Translational Medicine suggests a new way to correct facial atrophy of localized scleroderma (LoS) in patients. It shows how applying grafts made up of the patient’s own fat enhanced with adipose‐derived stem cells...

Wellington, FL — On June 14-18, 2021, the Regenerative Medicine Foundation (RMF) and Wake Forest Institute for Regenerative Medicine (WFIRM) will broadcast the combined event showcasing global experts, luminaries and visionaries from government, science, medicine,...

Diabetes Research Institute Investigators Will Lead the First Site Activated for the Vertex Study MIAMI, FL – April 6, 2021 – Researchers with the Diabetes Research Institute (DRI) at the University of Miami Miller School of Medicine and Vertex Pharmaceuticals...

Durham, NC – According to the results of a phase 1 clinical trial just published in STEM CELLS Translational Medicine, a new stem cell therapy shows promise of making diabetes-related amputations a thing of the past. The trial involved injecting diabetes patients...

Federal Funding for Large-Scale, Randomized, Controlled Trials is Needed to Confirm Results and Help Bring Safe and Effective Treatments to Patients in Need Washington, DC (March 24, 2021) – A new report released by Alliance for Cell Therapy Now, an independent,...

Durham, NC – The standard of treatment for bone tumors is often two-fold: surgery to remove the cancerous section followed by raadiation therapy to ensure all the cancerous cells have been killed off. This is an effective way to defeat bone tumors; however, it often...

MIAMI, March 11, 2021 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic aging-related and life-threatening conditions, announced today that the U.S. Food...

Durham, NC – Nuclear power offers an efficient, reliable way to provide energy to large populations – as long as all goes well. Accidents involving nuclear reactors such as those that took place in 1986 at Chernobyl and at Fukushima Daiichi after the March 2011...

Non-profit Editorial Platform Fosters Renewed Enthusiasm for Scientific Progress March 15, 2021 – LeapsMag, the award-winning online magazine created to encourage public discussion about scientific innovation, re-emerges today as Leaps.org, a non- profit media...

Summary:  Longitudinal imaging study provides evidence in patients that autologous bone marrow cells may lead to a reduction in white matter injury compared with stroke patients who did not receive bone marrow cells. Durham, NC – Results of a clinical trial released...

Results of a phase I clinical trial released in STEM CELLS Translational Medicine shows there is a strong possibility that stem cells may alleviate lymphedema, a chronic debilitating condition affecting up to one in three women treated for breast cancer. Durham, NC –...

—Assistant physician and Missouri state legislator indicted for wire fraud, other crimes by Kristina Fiore, Director of Enterprise & Investigative Reporting,  MedPage Today February 4, 2021 - A Missouri state lawmaker and medical professional was indicted by a...

JANUARY 19, 2021 —UTSA has launched a collaborative research institute that will benefit people suffering from a variety of vascular and other medical issues. The lnstitute of Regenerative Medicine will provide a unique resource and collection of research and...

Durham, NC – Karīna Narbute, Ph.D. is the latest recipient of STEM CELLS Translational Medicine’s Young Investigator Award. The award fosters advancements in the field of stem cells and regenerative medicine by honoring a young researcher who is the principal author...

International Society for Stem Cell Research Retinal cells derived from adult human eye stem cells survived when transplanted into the eyes of monkeys, an important early step in the validation of this approach for treating blindness, according to a study by Liu, et...

Durham, NC – Mid-term results of the first clinical trial designed specifically to evaluate the safety and effectiveness of two cell therapies that are showing early promise in treating angiitis-induced critical limb ischemia were released today in STEM CELLS...

Washington, DC (December 30, 2020) – Leaders of Alliance for Cell Therapy Now (ACT Now)—including representatives of academic and medical institutions, industry innovators, and patients—applaud Congress for its inclusion of important provisions in the final FY 2021...

Melbourne, Australia; December 18, and New York, USA; December 17, 2020: Mesoblast Limited (ASX:MSB; Nasdaq:MESO) today provided an update on the randomized controlled trial of remestemcel-L in ventilator-dependent patients with moderate to severe acute respiratory...